Abstract
Amyloid peptide fibrillogenesis induced by Cu(II) ions is a key event in the pathogenesis of Alzheimer’s disease. Dendrimers have been found to be active in preventing fibril formation. Therefore, they hold promise for the treatment of Alzheimer’s disease. In this study, the fibrillation mechanism of amyloid peptide Aβ 1-40 was studied by adding Cu(II) in the absence and presence of 4th generation poly(propyleneimine) glycodendrimer functionalized with sulfate groups, using dynamic light scattering (DLS), circular dichroism (CD), fluorescence, electron paramagnetic resonance (EPR) and molecular modeling (MD). The glycodendrimer was non-toxic to mHippoE-18 embryonic mouse hippocampal cells, selected as a nerve cell model, and decreased the toxicity of peptide aggregates formed after the addition of Cu(II). The binary systems of Cu(II)–glycodendrimer, Cu(II)–peptide, and glycodendrimer–peptide were first characterized. At the lowest Cu(II)/glycodendrimer molar ratios, Cu(II) was complexed by the internal-dendrimer nitrogen sites. After saturation of these sites, Cu(II) binding with sulfate groups occurred. Stable Cu(II)–peptide complexes formed within 5 min and were responsible for a transition from an α helix to a β-sheet conformation of Aβ 1-40. Glycodendrimer–peptide interactions provoked the stabilization of the α-helix, as demonstrated in the absence of Cu(II) by the Thioflavin T assay, and in the presence of Cu(II) by CD, EPR, and MD. Formation of fibrils is differentially modulated by glycodendrimer and Cu(II) concentrations for a fixed amount of Aβ 1-40. Therefore, this multidisciplinary study facilitated the recognition of optimal experimental conditions that allow the glycodendrimer to avoid the fibril formation induced by Cu(II).
Similar content being viewed by others
References
Bertram, L.; Tanzi, R. E. The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 2005, 115, 1449–1457.
Verma, M.; Vats, A.; Taneja, V. Toxic species in amyloid disorders: Oligomers or mature fibrils. Ann. Indian Acad. Neurol. 2015, 18, 138–145.
Olesen, J.; Gustavsson, A.; Svensson, M.; Wittchen, H.-U.; Jönsson, B. The economic cost of brain disorders in Europe. Eur. J. Neurol. 2012, 19, 155–162.
WHO. Dementia: Fact sheet N°362; World Health Organization: Geneva, 2015.
Seltzer, B.; Zolnouni, P.; Nunez, M.; Goldman, R.; Kumar, D.; Ieni, J.; Richardson, S. Donepezil "402" Study Group. Efficacy of donepezil in early-stage Alzheimer disease. A randomized placebo-controlled trial. Arch. Neurol. 2004, 61, 1852–1856.
Yiannopoulou, K. G.; Papageorgiou, S. G. Current and future treatments for Alzheimer’s disease. Ther. Adv. Neurol. Disord. 2013, 6, 19–33.
Colvin, V. L.; Kulinowski, K. M. Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. USA 2007, 104, 8679–8680.
Parveen, R.; Shamsi, T. N.; Fatima, S. Nanoparticles–protein interaction: Role in protein aggregation and clinical implications. Int. J. Biol. Macromol. 2017, 94, 386–395.
Cabaleiro-Lago, C.; Quinlan-Pluck, F.; Lynch, I.; Lindman, S.; Minogue, A. M.; Thulin, E.; Walsh, D. M.; Dawson, K. A.; Linse, S. Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 2008, 130, 15437–15443.
Ottaviani, M. F.; Mazzeo, R.; Cangiotti, M.; Fiorani, L.; Majoral, J. P.; Caminade, A. M.; Pedziwiatr, E.; Bryszewska, M.; Klajnert, B. Time evolution of the aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR. Biomacromolecules 2010, 11, 3014–3021.
Appelhans, D.; Benseny, N.; Klementiveva, O.; Bryszewska, M.; Klajnert, B.; Cladera, J. Dendrimers as antiamyloidogenic agents. Dendrimer-amyloid aggregates morphology and cell toxicity. In Dendrimers in Biomedical Applications; Klajnert, B.; Peng, L.; Cena, V., Eds.; RSC Publishing: Cambridge, UK, 2013; pp 1–13.
Aulenta, F.; Hayes, W.; Rannard, S. Dendrimers: A new class of nanoscopic containers and delivery devices. Eur. Polym. J. 2003, 39, 1741–1771.
Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Release 2000, 65, 133–148.
Barrett, T.; Ravizzini, G.; Choyke, P. L.; Kobayashi, H. Dendrimers in medical nanotechnology. IEEE Eng. Med. Biol. Mag. 2009, 28, 12–22.
Bullen, H. A.; Hemmer, R.; Haskamp, A.; Cason, C.; Wall, S.; Spaulding, R.; Rossow, B.; Hester, M.; Caroway, M.; Haik K. L. Evaluation of biotinylated PAMAM dendrimer toxicity in models of the blood brain barrier: A biophysical and cellular approach. J. Biomater. Nanobiotechnol. 2011, 2, 485–493.
Appelhans, D.; Klajnert-Maculewicz, B.; Janaszewska, A.; Lazniewska, J.; Voit, B. Dendritic glycopolymers based on dendritic polyamine scaffolds: View on their synthetic approaches, characteristics and potential for biomedical applications. Chem. Soc. Rev. 2015, 44, 3968–3996.
Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Bryszewska, M. Influence of dendrimer’s structure on its activity against amyloid fibril formation. Biochem. Biophys. Res. Commun. 2006, 345, 21–28.
Klajnert, B.; Cortijo-Arellano, M.; Bryszewska, M.; Cladera, J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer’s and prion diseases. Biochem. Biophys. Res. Commun. 2006, 339, 577–582.
Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Majoral, J. P.; Caminade, A.-M.; Bryszewska M. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185–208. Biochem. Biophys. Res. Commun. 2007, 364, 20–25.
Klementieva, O.; Benseny-Cases, N.; Gella, A.; Appelhans, D.; Voit, B.; Cladera, J. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer’s disease. Amyloid-dendrimer aggregates morphology and cell toxicity. Biomacromolecules 2011, 12, 3903–3909.
Benseny-Cases, N.; Klementieva, O.; Cladera, J. Dendrimers antiamyloidogenic potential in neurodegenerative diseases. New J. Chem. 2012, 36, 211–216.
Wasiak, T.; Ionov, M.; Nieznanski, K.; Nieznanska, H.; Klementieva, O.; Granell, M.; Cladera, J.; Majoral, J.-P.; Caminade, A.-M.; Klajnert, B. Phosphorus dendrimers affect Alzheimer’s (Aβ1–28) peptide and MAP-Tau protein aggregation. Mol. Pharm. 2012, 9, 458–469.
McCarthy, J. M.; Moreno, B. R.; Filippini, D.; Komber, H.; Maly, M.; Cernescu, M.; Brutschy, B.; Appelhans, D.; Rogers, M. S. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity. Biomacromolecules 2013, 14, 27–37.
Milowska, K.; Malachowska, M.; Gabryelak, T. PAMAM G4 dendrimers affect the aggregation of α-synuclein. Int. J. Biol. Macromol. 2011, 48, 742–746.
Milowska, K.; Gabryelak, T.; Bryszewska, M.; Caminade, A.-M.; Majoral, J.-P. Phosphorus-containing dendrimers against α-synuclein fibril formation. Int. J. Biol. Macromol. 2012, 50, 1138–1143.
Milowska, K.; Grochowina, J.; Katir, N.; El Kadib, A.; Majoral, J.-P.; Bryszewska, M.; Gabryelak T. Interaction between viologen-phosphorus dendrimers and α-synuclein. J. Lumin. 2013, 134, 132–137.
Milowska, K.; Grochowina, J.; Katir, N.; El Kadib, A.; Majoral, J.-P.; Bryszewska, M.; Gabryelak T. Viologen-phosphorus dendrimers inhibit α-synuclein fibrillation. Mol. Pharm. 2013, 10, 1131–1137.
Zeliger, H. I.; Lipinski, B. Physiochemical basis of human degenerative disease. Interdiscip. Toxicol. 2015, 8, 15–21.
Crichton, R. R.; Ward, R. J. Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies; John Wiley & Sons: Chichester, 2006.
Crichton, R. R.; Ward, R. J. Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies, 2nd ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2014.
Gaggelli, E.; Kozlowski, H.; Valensin, D.; Valensin, G. Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis). Chem. Rev. 2006, 106, 1995–2044.
Kozlowski, H.; Janicka-Klos, A.; Brasun, J.; Gaggelli, E.; Valensin, D.; Valensin G. Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation). Coord. Chem. Rev. 2009, 253, 2665–2685.
Faller, P.; Hureau, C.; La Penna, G. Metal ions and intrinsically disordered proteins and peptides: From Cu/Zn amyloid-β to general principles. Acc. Chem. Res. 2014, 47, 2252–2259.
Karr, J. W.; Kaupp L. J.; Szalai V. A. Amyloid-β binds Cu2+ in a mononuclear metal ion binding site. J. Am. Chem. Soc. 2004, 126, 13534–13538.
Liu, S. T.; Howlett, G.; Barrow, C. J. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer’s disease. Biochemistry 1999, 38, 9373–9378.
La Penna, G.; Hureau, C.; Andreussi, O.; Faller, P. Identifying, by first-principles simulations, Cu[amyloid-β]_species making Fenton-type reactions in Alzheimer’s disease. J. Phys. Chem. B 2013, 117, 16455–16467.
Kozłowski, H.; Luczkowski, M.; Valensin, D.; Valensin, G. Metal ion binding properties of proteins related to neurodegeneration. In Neurodegenerative Diseases and Metal Ions: Metal Ions in Life Science, vol. 1; Sigel, A.; Sigel, H.; Sigel, R. K. O., Eds.; John Wiley & Sons, Ltd.: Chichester, UK, 2006.
Vašák, M.; Meloni, G. Metallothionein-3, zinc, and copper in the central nervous system. In Metallothioneins and Related Chelators; Sigel, A.; Sigel, H.; Sigel, R. K. O., Eds.; The Royal Society of Chemistry: Cambridge, 2009; pp 319–352.
Klementieva, O.; Aso, E.; Filippini, D.; Benseny-Cases, N.; Carmona, M.; Juvés, S.; Appelhans, D.; Cladera, J.; Ferrer, I. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer’s disease. Biomacromolecules 2013, 14, 3570–3580.
Klajnert, B.; Appelhans, D.; Komber, H.; Morgner, N.; Schwarz, S.; Richter, S.; Brutschy, B.; Ionov, M.; Tonkikh, A. K.; Bryszewska, M. et al. The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: New effects dependent on Hydrogen bonding. Chem.-Eur. J. 2008, 14, 7030–7041.
McCarthy, J. M.; Franke, M.; Resenberger, U. K.; Waldron, S.; Simpson, J. C.; Tatzelt, J.; Appelhans, D.; Rogers, M. S. Anti-prion drug mPPIg5 inhibits PrPC conversion to PrPSc. PLoS One 2013, 8, e55282.
Furlan, S.; La Penna, G.; Appelhans, D.; Cangiotti, M.; Ottaviani, M. F.; Danani, A. Combined EPR and molecular modeling study of PPI dendrimers interacting with copper ions: Effect of generation and maltose decoration. J. Phys. Chem. B 2014, 118, 12098–12111.
Ziemba, B.; Janaszewska, A; Ciepluch, K; Krotewicz, M.; Fogel, W. A.; Appelhans, D.; Voit, B.; Klajnert, B.; Bryszewska, M. In vivo toxicity of poly(propyleneimine) dendrimers. J. Biomed. Mater. Res. Part A 2011, 99, 261–268.
Rossi, J. C.; Maret, B.; Vidot, K.; Francoia, J. P.; Cangiotti, M.; Lucchi, S.; Coppola, C.; Ottaviani, M. F. Multi-technique characterization of poly-L-lysine dendrigrafts-Cu(II) complexes for biocatalysis. Macromol. Biosci. 2015, 15, 275–290.
Ottaviani, M. F.; El Brahmi, N.; Cangiotti, M.; Coppola, C.; Buccella, F.; Cresteil, T.; Mignani, S.; Caminade, A. M.; Costes, J. P.; Majoral, J.-P. Comparative EPR studies of Cu(II)-conjugated phosphorous-dendrimers in the absence and presence of normal and cancer cells. RSC Adv. 2014, 4, 36573–36583.
Ottaviani, M. F.; Cangiotti, M.; Fattori, A.; Coppola, C.; Lucchi, S.; Ficker, M.; Petersen, J. F.; Christensen, J. B. Copper(II) complexes with 4-carbomethoxypyrrolidone functionalized PAMAM-dendrimers: An EPR study. J. Phys. Chem. B 2013, 117, 14163–14172.
Apicella, A.; Soncini, M.; Deriu, M. A.; Natalello, A.; Bonanomi, M.; Dellasega, D.; Tortora, P.; Regonesi, M. E.; Casari, C. S. A hydrophobic gold surface triggers misfolding and aggregation of the amyloidogenic Josephin domain in monomeric form, while leaving the oligomers unaffected. PLoS One 2013, 8, e58794.
Grasso, G.; Tuszynski, J. A.; Morbiducci, U.; Licandro, G.; Danani, A.; Deriu, M. A. Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: Evidences from replica exchange molecular dynamics. Biol. Direct 2017, 12, 2.
Deriu, M. A.; Grasso, G.; Tuszynski, J. A.; Gallo, D.; Morbiducci, U.; Danani, A. Josephin Domain structural conformations explored by metadynamics in essential coordinates. PLoS Comput. Biol. 2016, 12, e1004699.
Deriu, M. A.; Grasso, G.; Licandro, G.; Danani, A.; Gallo, D.; Tuszynski, J. A.; Morbiducci, U. Investigation of the Josephin domain protein–protein interaction by molecular dynamics. PLoS One 2014, 9, e108677.
Soncini, M.; Vesentini, S.; Ruffoni, D.; Orsi, M.; Deriu, M. A.; Redaelli, A. Mechanical response and conformational changes of alpha-actinin domains during unfolding: A molecular dynamics study. Biomech. Model. Mechanobiol. 2007, 6, 399–407.
Garzoni, M.; Cheval, N.; Fahmi, A.; Danani, A.; Pavan, G. M. Ion-selective controlled assembly of dendrimer-based functional nanofibers and their ionic-competitive disassembly. J. Am. Chem. Soc. 2012, 134, 3349–3357.
Popescu, L. M.; Piticescu, R. M.; Doni, G.; Danani, A. Interfacial interactions of Fe3+ with PAMAM dendrimer in different pressure conditions. Molecular dynamics. Rev. Roum. Chim. 2012, 57, 35–38.
Deriu, M. A.; Popescu, L. M.; Ottaviani, M. F.; Danani, A.; Piticescu, R. M. Iron oxide/PAMAM nanostructured hybrids: Combined computational and experimental studies. J. Mater. Sci. 2016, 51, 1996–2007.
Boye, S.; Ennen, E.; Scharfenberg, L.; Appelhans, D.; Nilsson, L.; Lederer, A. From 1D rods to 3D networks: A biohybrid topological diversity investigated by asymmetrical flow field-flow fractionation. Macromolecules 2015, 48, 4607–4619.
Tomalia, D. A.; Rookmaker, M. Poly (propylene imine) dendrimers. In Polymer Data Handbook, 2nd ed.; Mark, J. E., Ed.; Oxford University Press: New York, 2009; pp 979–982.
Louis-Jeune, C.; Andrade-Navarro, M. A.; Perez-Iratxeta, C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins 2012, 80, 374–381.
Budil, D. E.; Lee, S.; Saxena, S.; Freed, J. H. Nonlinear-least-squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg–Marquardt algorithm. J. Magn. Reson. Ser. A 1996, 120, 155–189.
Wogulis, M.; Wright, S.; Cunningham, D.; Chilcote, T.; Powell, K.; Rydel, R. E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci. 2005, 25, 1071–1080.
Coles, M.; Bicknell, W.; Watson, A. A.; Fairlie, D. P.; Craik, D. J. Solution structure of amyloid β-peptide(1–40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 1998, 37, 11064–11077.
Boopathi, S.; Kolandaivel, P. Role of zinc and copper metal ions in amyloid β-peptides Aβ1–40 and Aβ1–42 aggregation. RSC Adv. 2014, 4, 38951–38965.
Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006, 65, 712–725.
Lindorff-Larsen, K.; Piana, S.; Palmo, K.; Maragakis, P.; Klepeis, J. L.; Dror, R. O.; Shaw, D. E. Improved sidechain torsion potentials for the Amber ff99SB protein force field. Proteins 2010, 78, 1950–1958.
Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926–935.
Lindorff-Larsen, K.; Maragakis, P.; Piana, S.; Eastwood, M. P.; Dror, R. O.; Shaw, D. E. Systematic validation of protein force fields against experimental data. PLoS One 2012, 7, e32131.
Robertazzi, A.; Vargiu, A. V.; Magistrato, A.; Ruggerone, P.; Carloni, P.; de Hoog, P.; Reedijk, J. Copper-1,10-phenanthroline complexes binding to DNA: Structural predictions from molecular simulations. J. Phys. Chem. B 2009, 113, 10881–10890.
Pavan, G. M.; Posocco, P.; Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.; Ragg, E.; Catapano, C. V.; Pricl, S. PAMAM dendrimers for siRNA delivery: Computational and experimental insights. Chem.-Eur. J. 2010, 16, 7781–7795.
Pavan, G. M.; Monteagudo, S.; Guerra, J.; Carrión, B.; Ocaña, V.; Rodríguez-Lopez, J.; Danani, A.; Pérez-Martínez, F. C.; Ceña, V. Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers. Curr. Med. Chem. 2012, 19, 4929–4941.
Jensen, L. B.; Pavan, G. M.; Kasimova, M. R.; Rutherford, S.; Danani, A.; Nielsen, H. M.; Foged, C. Elucidating the molecular mechanism of PAMAM-siRNA dendriplex selfassembly: Effect of dendrimer charge density. Int. J. Pharm. 2011, 416, 410–418.
Pavan, G. M.; Albertazzi, L.; Danani, A. Ability to adapt: Different generations of PAMAM dendrimers show different behaviors in binding siRNA. J. Phys. Chem. B 2010, 114, 2667–2675.
Maingi, V.; Jain, V.; Bharatam, P. V.; Maiti, P. K. Dendrimer building toolkit: Model building and characterization of various dendrimer architectures. J. Comput. Chem. 2012, 33, 1997–2011.
Mukherjee, G.; Patra, N.; Barua, P.; Jayaram, B. A fast empirical GAFF compatible partial atomic charge assignment scheme for modeling interactions of small molecules with biomolecular targets. J. Comput. Chem. 2011, 32, 893–907.
da Silva, A. W. S.; Vranken, W. F. ACPYPE—AnteChamber PYthon parser interfacE. BMC Res. Notes 2012, 5, 367.
Dupradeau, F. Y.; Pigache, A.; Zaffran, T.; Savineau, C.; Lelong, R.; Grivel, N.; Lelong, D.; Rosanski, W.; Cieplak, P. The R.E.D. tools: Advances in RESP and ESP charge derivation and force field library building. Phys. Chem. Chem. Phys. 2010, 12, 7821–7839.
Vanquelef, E.; Simon, S.; Marquant, G.; Garcia, E.; Klimerak, G.; Delepine, J. C.; Cieplak, P.; Dupradeau, F. Y. R.E.D. Server: A web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments. Nucleic Acids Res. 2011, 39, W511–W517.
Bayly, C. I.; Cieplak, P.; Cornell, W.; Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J. Phys. Chem. 1993, 97, 10269–10280.
Bussi, G.; Donadio, D.; Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007, 126, 014101.
Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684–3690.
Nosé, S.; Klein, M. L. Constant pressure molecular dynamics for molecular systems. Mol. Phys. 1983, 50, 1055–1076.
Parrinello, M.; Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981, 52, 7182–7190.
Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008, 4, 435–447.
Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38.
Ulucan, O.; Jaitly, T.; Helms, V. Energetics of hydrophilic protein–protein association and the role of water. J. Chem. Theory Comput. 2014, 10, 3512–3524.
Grasso, G.; Deriu, M. A.; Prat, M.; Rimondini, L.; Vernè, E.; Follenzi, A.; Danani, A. Cell penetrating peptide adsorption on magnetite and silica surfaces: A computational investigation. J. Phys. Chem. B 2015, 119, 8239–8246.
De Moura, D. C.; Bryksa, B. C.; Yada, R. Y. In silico insights into protein–protein interactions and folding dynamics of the saposin-like domain of Solanum tuberosum aspartic protease. PLoS One 2014, 9, e104315.
Lemkul, J. A.; Bevan, D. R. Assessing the stability of Alzheimer’s amyloid protofibrils using molecular dynamics. J. Phys. Chem. B 2010, 114, 1652–1660.
Kumar, S.; Rosenberg, J. M.; Bouzida, D.; Swendsen, R. H.; Kollman, P. A. The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J. Comput. Chem. 1992, 13, 1011–1021.
Gkeka, P.; Angelikopoulos, P.; Sarkisov, L.; Cournia, Z. Membrane partitioning of anionic, ligand-coated nanoparticles is accompanied by ligand snorkeling, local disordering, and cholesterol depletion. PLoS Comput. Biol. 2014, 10, e1003917.
Grasso, G.; Deriu, M. A.; Tuszynski, J. A.; Gallo, D.; Morbiducci, U.; Danani, A. Conformational fluctuations of the AXH monomer of Ataxin-1. Proteins 2016, 84, 52–59.
Kannappan, R.; Rousselin, Y.; Jabri, R. Z.; Goze, C.; Brandès, S.; Guilard, R.; Zrineh, A.; Denat, F. Synthesis, structure and coordination properties of three cyclam-based ligands bearing one scorpionate arm. Inorg. Chim. Acta 2011, 373, 150–158.
Alves, L. G.; Souto, M.; Madeira, F.; Adão, P.; Munhá, R. F.; Martins, A. M. Syntheses and solid state structures of cyclam-based copper and zinc compounds. J. Organomet. Chem. 2014, 760, 130–137.
Lima, L. M. P.; Esteban-Gómez, D.; Delgado, R.; Platas-Iglesias, C.; Tripier, R. Monopicolinate cyclen and cyclam derivatives for stable copper(II) complexation. Inorg. Chem., 2012, 51, 6916–6927.
Dorlet, P.; Gambarelli, S.; Faller, P.; Hureau, C. Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1–16 Amyloid-β peptide: A key role of the first two N-terminus residues. Angew. Chem., Int. Ed. 2009, 48, 9273–9276.
Drew, S. C.; Masters, C. L.; Barnham, K. J. J. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer’s disease amyloid-β peptide—Relevance to N-terminally truncated forms. J. Am. Chem. Soc. 2009, 131, 8760–8761.
Drew, S. C.; Noble, C. J.; Masters, C. L.; Hanson, G. R.; Barnham, K. J. Pleomorphic copper coordination by Alzheimer’s disease amyloid-β peptide. J. Am. Chem. Soc. 2009, 131, 1195–1207.
Hureau, C.; Dorlet P. Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 2: Dependence of Cu(II) binding sites with Aβ sequences. Coord. Chem. Rev. 2012, 256, 2175–2187.
Opazo, C.; Ruiz, F. H.; Inestrosa N. C. Amyloid-β-peptide reduces copper(II) to copper(I) independent of its aggregation state. Biol. Res. 2000, 33, 125–131.
Faller, P.; Hureau, C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide. Dalton Trans. 2009, 1080–1094.
Azimi, S.; Rauk, A. On the involvement of copper binding to the N-terminus of the amyloid beta peptide of Alzheimer’s disease: A computational study on model systems. Int. J. Alzheimers Dis. 2011, 2011, 539762.
Lv, Z. J.; Roychaudhuri, R.; Condron, M. M.; Teplow, D. B.; Lyubchenko, Y. L. Mechanism of amyloid β-protein dimerization determined using single-molecule AFM force spectroscopy. Sci. Rep. 2013, 3, 2880.
Acknowledgements
We wish to thank our students: Pawel Piatek and Agnieszka Karenko for their assistance with the collection of a part of the data. Authors also thank Mrs. Christiane Effenberg for synthesizing the glycodendirmer, Dr. Hartmut Komber for NMR measurements and Dr. Susanne Boye for AF4 measurements.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
12274_2017_1734_MOESM1_ESM.pdf
Multivalent interacting glycodendrimer to prevent amyloid-peptide fibril formation induced by Cu(II): A multidisciplinary approach
Rights and permissions
About this article
Cite this article
Janaszewska, A., Klajnert-Maculewicz, B., Marcinkowska, M. et al. Multivalent interacting glycodendrimer to prevent amyloid-peptide fibril formation induced by Cu(II): A multidisciplinary approach. Nano Res. 11, 1204–1226 (2018). https://doi.org/10.1007/s12274-017-1734-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-017-1734-9